SCHIZOAFFECITVE DISORDER

Clinical trials for SCHIZOAFFECITVE DISORDER explained in plain language.

Never miss a new study

Get alerted when new SCHIZOAFFECITVE DISORDER trials appear

Sign up with your email to follow new studies for SCHIZOAFFECITVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Scientists scan brains to see if new drug hits target in schizophrenia

Knowledge-focused Not yet recruiting

This study aims to understand how an experimental drug called Cobenfy affects brain chemistry in people with schizophrenia. Twelve participants will receive one of three doses for five weeks and undergo special brain scans before and after treatment. The main goal is to measure i…

Matched conditions: SCHIZOAFFECITVE DISORDER

Phase: PHASE1, PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused

Last updated Mar 19, 2026 14:56 UTC

SCHIZOAFFECITVE DISORDER

Get alerted when new SCHIZOAFFECITVE DISORDER trials appear

Scientists scan brains to see if new drug hits target in schizophrenia